SMO and cancer: SMO-independent activation of GLI1 has been detected in several malignant tumors such as esophageal adenocarcinoma whereby activated S6K1 phosphorylates GLI1 at Ser84 to induce GLI1 transcriptional activity and oncogenic functions [41].